Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth

Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth

Franck Gallardo,1 Bernard Mariamé,2 Remi Gence,3 Anne-Francoise Tilkin-Mariamé4 1NeoVirTech, SAS, Institut for Advanced Technology in Life Science (ITAV), Toulouse, France; 2ITAV USR3505 CNRS/LBME, UMR 5099 CNRS, Toulouse, France; 3INSERM UMR 1037, CRCT, University of Toulouse...

Full description

Bibliographic Details
Main Authors: Gallardo F, Mariamé B, Gence R, Tilkin-Mariamé AF
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Drug Design, Development and Therapy
Subjects:
Nasopharyngeal carcinoma
Ivermectin
macrocyclic lactones
P21-Activated Kinase1 and cytotoxicity.
Online Access:https://www.dovepress.com/macrocyclic-lactones-inhibit-nasopharyngeal-carcinoma-cells-proliferat-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/macrocyclic-lactones-inhibit-nasopharyngeal-carcinoma-cells-proliferat-peer-reviewed-article-DDDT

Similar Items